Sertraline Treatment of Major Depression in Patients With Acute MI or Unstable Angina
Author(s) -
Alexander H. Glassman
Publication year - 2002
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.288.6.701
Subject(s) - medicine , sertraline , unstable angina , major depressive disorder , ejection fraction , placebo , myocardial infarction , depression (economics) , angina , randomized controlled trial , adverse effect , clinical global impression , cardiology , heart failure , antidepressant , alternative medicine , macroeconomics , pathology , amygdala , hippocampus , economics
Major depressive disorder (MDD) occurs in 15% to 23% of patients with acute coronary syndromes and constitutes an independent risk factor for morbidity and mortality. However, no published evidence exists that antidepressant drugs are safe or efficacious in patients with unstable ischemic heart disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom